Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Allergy Development in Adulthood: An Occupational Cohort Study of the Manufacturing of Industrial Enzymes

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Fatal pneumococcus meningitis in a child with complement factor ficolin-3 deficiency

    Research output: Contribution to journalComment/debateResearchpeer-review

  2. Hematopoietic Stem Cell Transplantation as Treatment for Patients with DOCK8 Deficiency

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Reply to Crépeaux et al and Blasco

    Research output: Contribution to journalComment/debateResearchpeer-review

  4. Evidence Refuting the Existence of Autoimmune/Autoinflammatory Syndrome Induced by Adjuvants (ASIA)

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. House Dust Mite Respiratory Allergy: An Overview of Current Therapeutic Strategies

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: Occupational allergy may serve as a model of allergy development in adults.

OBJECTIVE: We aimed at describing respiratory allergy and IgE sensitization across different exposure strata defined by time, technology, and exposure control.

METHODS: In a retrospective (1970-2017) cohort of industrial enzyme production employees, monitored by an occupational medical center, 5024 individuals were surveyed. Five exposure groups and risk levels for sensitization and allergic disease were analyzed on the basis of demographic characteristics, hiring decade, and smoking status.

RESULTS: Of all persons entering the company 47 years from 1970, 149 developed occupational allergy (incidence rate, 2.72/1000 person-years). In a multivariate cause-specific Cox proportional hazards model, the hazard of allergy was significantly related to decade of recruitment. Compared with the 1970s, the hazard ratio (HR) uniformly decreased from 0.85 (95% CI, 0.57-1.27) in the 1980s to 0.16 (95% CI, 0.05-0.52) in the 2010s. Compared with expected highest exposed group, the HRs were 0.48 (95% CI, 0.31-76) and 0.13 (95% CI, 0.06-0.30) in less exposed production areas and 0.92 (95% CI, 0.48-1.73) and 0.23 (95% CI, 0.10-0.53) in different laboratory areas. The HR of smoking was 2.03 (95% CI, 1.41-2.93). The pattern of sensitizations also showed clear associations to recruitment decade, exposure, and smoking. Among individuals sensitized but not yet allergic, a high IgE level was the only risk factor (HR, 3.03; 95% CI, 1.82-5.04) for subsequent allergy development.

CONCLUSIONS: The impact of exposure is dose-related and linked to the sensitization step, which may subsequently lead to allergy development. For primary prevention of enzyme allergy, exposure control is mandatory and achievable despite increasing production volumes.

Original languageEnglish
JournalThe journal of allergy and clinical immunology. In practice
Volume8
Issue number1
Pages (from-to)210-218.e5
ISSN2213-2198
DOIs
Publication statusPublished - Jan 2020

ID: 59044893